Figure 2From: MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer Carboplatin sensitivity and silencing of the candidate genes. Dose–response curves of each cell line against carboplatin, after 48 hours drug administration (A). Relative viability after 48 hours carboplatin administration and silencing of four genes compared to the negative control siRNA transfected groups in each of the four cell lines (mean with SEM) *p < 0.001, **p < 0.01 (B).Back to article page